loader from loading.io

BTK Inhibitors in Multiple Sclerosis Treatment - Part 1

Neurology Minute

Release Date: 04/24/2025

False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1 show art False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice - Part 1

Neurology Minute

In part one of this two-part series, Dr. Stacey Clardy and Dr. Elia Sechi discuss the clinical scenarios where the commonly used assay for myasthenia gravis is most likely to produce false positive results in patients who do not actually have myasthenia gravis. Show reference:   

info_outline
Transforming Neurology Education: Evaluating Teaching Incentive Programs show art Transforming Neurology Education: Evaluating Teaching Incentive Programs

Neurology Minute

Dr. Roy E. Strowd and Dr. Susannah Cornes discuss a teaching incentive initiative designed to support and reward faculty in academic neurology.  Show reference:  

info_outline
Optic Nerve Imaging - Part 1 show art Optic Nerve Imaging - Part 1

Neurology Minute

In the first installment of this three-part series, Dr. Elizabeth Zollos explores how optical coherence tomography is advancing our understanding of multiple sclerosis and enhancing diagnostic accuracy.   

info_outline
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2 show art Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 2

Neurology Minute

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer explore the subcategories of Lewy body disease, focusing on the body-first subtype Show reference:  

info_outline
AAN’s President’s Award Recipient for 2025 - Part 2 show art AAN’s President’s Award Recipient for 2025 - Part 2

Neurology Minute

In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN.  Show reference:    

info_outline
Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1 show art Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals - Part 1

Neurology Minute

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference:  

info_outline
AAN’s President’s Award Recipient for 2025 - Part 1 show art AAN’s President’s Award Recipient for 2025 - Part 1

Neurology Minute

In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference:   

info_outline
Progressive Multiple Sclerosis show art Progressive Multiple Sclerosis

Neurology Minute

Dr. Jeff Lambe talks about progressive multiple sclerosis.  Show references:    

info_outline
Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes show art Neuroimmunology Update 2025: Autoimmune Encephalitis Outcomes

Neurology Minute

Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes.  Show reference:   

info_outline
Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2 show art Understanding Blood-Based Biomarkers in Alzheimer Disease - Part 2

Neurology Minute

In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

info_outline
 
More Episodes

In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. 

Show reference:

https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 

https://www.nejm.org/doi/full/10.1056/NEJMoa2415988